What is the life expectancy of someone with Arterial Tortuosity Syndrome?

Arterial Tortuosity Syndrome is a rare connective tissue disorder characterized by the elongation and twisting of major arteries, with a prognosis that varies significantly depending on the severity of cardiovascular involvement. While life expectancy in Arterial Tortuosity Syndrome can be impacted by serious complications like aortic dissection or stenosis, many individuals live into adulthood with proactive medical monitoring and timely surgical interventions.

What factors influence the prognosis of Arterial Tortuosity Syndrome?

The clinical course of Arterial Tortuosity Syndrome is highly variable, even among family members. The primary determinants of long-term health include the degree of arterial elongation and the presence of stenotic (narrowing) lesions in the pulmonary or systemic arteries. Because Arterial Tortuosity Syndrome is caused by mutations in the SLC2A10 gene, which affects glucose transport and transforming growth factor-beta (TGF-β) signaling, the systemic impact on connective tissue can range from mild to severe. Early identification of these vascular changes is the most critical factor in managing the risks associated with the disease.

How have outcomes for Arterial Tortuosity Syndrome improved?

In recent decades, advancements in diagnostic imaging—such as magnetic resonance angiography (MRA) and computed tomography angiography (CTA)—have allowed for earlier detection of Arterial Tortuosity Syndrome. Improved surgical techniques and better understanding of the condition's progression have shifted the focus toward preventive management. Today, clinical care centers on reducing hemodynamic stress on the vessel walls, which has significantly improved the quality of life for those living with Arterial Tortuosity Syndrome.

What does long-term management look like?

Effective management requires a multidisciplinary approach to monitor vascular health and address complications before they become life-threatening. Key components of a proactive care plan include:

• Regular screening via echocardiography and full-body MRA to track arterial progression.


• Strict blood pressure control to reduce mechanical stress on weakened arterial walls.


• Consultations with cardiologists and vascular surgeons experienced in rare connective tissue disorders.


• Psychosocial support to navigate the challenges of living with a chronic, multisystem condition.

Next steps

• Consult with a specialized geneticist to confirm the diagnosis and discuss family screening.


• Establish a long-term care plan with a team of cardiologists and vascular specialists.


• Connect with the Arterial Tortuosity Syndrome community at DiseaseMaps.org to share experiences with others.


• Maintain a consistent schedule of imaging follow-ups, even when feeling asymptomatic.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

• Orphanet: Arterial Tortuosity Syndrome (ORPHA:93922)


• NIH Genetic and Rare Diseases Information Center (GARD): Arterial Tortuosity Syndrome


• OMIM (Online Mendelian Inheritance in Man): Arterial Tortuosity Syndrome (#208050)


• PubMed: Clinical and genetic aspects of Arterial Tortuosity Syndrome